A detailed history of Creative Financial Designs Inc transactions in Cassava Sciences Inc stock. As of the latest transaction made, Creative Financial Designs Inc holds 152 shares of SAVA stock, worth $4,248. This represents 0.0% of its overall portfolio holdings.

Number of Shares
152
Previous 152 -0.0%
Holding current value
$4,248
Previous $1,000 300.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 01, 2024

BUY
$18.44 - $26.41 $221 - $316
12 Added 8.57%
152 $3,000
Q1 2022

Apr 15, 2022

BUY
$32.6 - $53.05 $4,238 - $6,896
130 Added 1300.0%
140 $5,000
Q4 2021

Jan 26, 2022

BUY
$36.77 - $90.91 $367 - $909
10 New
10 $0

Others Institutions Holding SAVA

About CASSAVA SCIENCES INC


  • Ticker SAVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,097,900
  • Market Cap $1.12B
  • Description
  • Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...
More about SAVA
Track This Portfolio

Track Creative Financial Designs Inc Portfolio

Follow Creative Financial Designs Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Financial Designs Inc , based on Form 13F filings with the SEC.

News

Stay updated on Creative Financial Designs Inc with notifications on news.